These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8388207)
21. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase. Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770 [TBL] [Abstract][Full Text] [Related]
23. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause]. Scarabin PY; Plu-Bureau G Arch Mal Coeur Vaiss; 1993 Feb; 86(2):243-8. PubMed ID: 8363427 [TBL] [Abstract][Full Text] [Related]
24. The role of estrogens as a risk factor for stroke in postmenopausal women. Rosenberg SH; Fausone V; Clark R West J Med; 1980 Oct; 133(4):292-6. PubMed ID: 7347044 [TBL] [Abstract][Full Text] [Related]
25. Cause-specific mortality in women receiving hormone replacement therapy. Schairer C; Adami HO; Hoover R; Persson I Epidemiology; 1997 Jan; 8(1):59-65. PubMed ID: 9116097 [TBL] [Abstract][Full Text] [Related]
26. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. Wilson PW; Garrison RJ; Castelli WP N Engl J Med; 1985 Oct; 313(17):1038-43. PubMed ID: 2995808 [TBL] [Abstract][Full Text] [Related]
27. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland. Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638 [TBL] [Abstract][Full Text] [Related]
28. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Falkeborn M; Persson I; Adami HO; Bergström R; Eaker E; Lithell H; Mohsen R; Naessén T Br J Obstet Gynaecol; 1992 Oct; 99(10):821-8. PubMed ID: 1419993 [TBL] [Abstract][Full Text] [Related]
29. Estrogen replacement therapy and fibrocystic breast disease. Pastides H; Najjar MA; Kelsey JL Am J Prev Med; 1987; 3(5):282-6. PubMed ID: 2838061 [TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect. Yuen J; Persson I; Bergkvist L; Hoover R; Schairer C; Adami HO Cancer Causes Control; 1993 Jul; 4(4):369-74. PubMed ID: 8394149 [TBL] [Abstract][Full Text] [Related]
31. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies. Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179 [TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Naessén T; Persson I; Adami HO; Bergström R; Bergkvist L Ann Intern Med; 1990 Jul; 113(2):95-103. PubMed ID: 2360759 [TBL] [Abstract][Full Text] [Related]